EGFR and neoplasm: The EGFR gene mutation and ALK-EML4 rearrangement in the lung adenocarcinoma and squamous cell carcinoma encouraged us to explore the tumor origin, and both tumors presented as treatment-naïve mutants occurring synchronously.